Gene · 6372
Papers3,275
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,275
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aptamer-Based Proteomics Measuring Preoperative Cerebrospinal Fluid Protein Alterations Associated with Postoperative Delirium. | Biomolecules | 2023 | 37759795 | PubTator, text mining | PubMed |
| Integration of Omics Data and Network Models to Unveil Negative Aspects of SARS-CoV-2, from Pathogenic Mechanisms to Drug Repurposing. | Biology (Basel) | 2023 | 37759595 | PubTator, text mining | PubMed |
| Development and Degeneration of the Intervertebral Disc-Insights from Across Species. | Vet Sci | 2023 | 37756062 | PubTator, text mining | PubMed |
| A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study. | QJM | 2023 | 37740371 | PubTator, text mining | PubMed |
| CRB3 navigates Rab11 trafficking vesicles to promote γTuRC assembly during ciliogenesis. | Elife | 2023 | 37737843 | PubTator, text mining | PubMed |
| ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis. | Hum Genomics | 2023 | 37735492 | PubTator, text mining | PubMed |
| CMTM6 as a potential therapy target is associated with immunological tumor microenvironment and can promote migration and invasion in pancreatic adenocarcinoma. | Funct Integr Genomics | 2023 | 37726578 | PubTator, text mining | PubMed |
| Severe pneumonia and pathogenic damage in human airway epithelium caused by Coxsackievirus B4. | Emerg Microbes Infect | 2023 | 37725516 | PubTator, text mining | PubMed |
| Spatial transcriptomics analysis of neoadjuvant cabozantinib and nivolumab in advanced hepatocellular carcinoma identifies independent mechanisms of resistance and recurrence. | Genome Med | 2023 | 37723590 | PubTator, text mining | PubMed |
| Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling. | Nat Commun | 2023 | 37717048 | PubTator, text mining | PubMed |
| Construction and validation of a signature for T cell-positive regulators related to tumor microenvironment and heterogeneity of gastric cancer. | Front Immunol | 2023 | 37711621 | PubTator, text mining | PubMed |
| Synovial-fluid-derived microparticles express vimentin and GRP78 in their surface and exhibit an in vitro stimulatory effect on fibroblast-like synoviocytes in rheumatoid arthritis. | Int J Rheum Dis | 2023 | 37695005 | PubTator, text mining | PubMed |
| Predicting sepsis using a combination of clinical information and molecular immune markers sampled in the ambulance. | Sci Rep | 2023 | 37691028 | PubTator, text mining | PubMed |
| TMT-Based Quantitative Proteomics Analysis Reveals Differentially Expressed Proteins between Different Sources of hMSCs. | Int J Mol Sci | 2023 | 37686351 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes. | Int J Mol Sci | 2023 | 37686093 | PubTator, text mining | PubMed |
| Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer. | Cardiovasc Toxicol | 2023 | 37684436 | PubTator, text mining | PubMed |
| Single-cell transcriptomes reveal a molecular link between diabetic kidney and retinal lesions. | Commun Biol | 2023 | 37670124 | PubTator, text mining | PubMed |
| Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences. | Front Immunol | 2023 | 37662901 | PubTator, text mining | PubMed |
| Systems analysis reveals differential expression of endocervical genes in African women randomized to DMPA-IM, LNG implant or cu-IUD. | Clin Immunol | 2023 | 37660744 | PubTator, text mining | PubMed |
| Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients. | Medicine (Baltimore) | 2023 | 37653738 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6372/papers?page=18